DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4fhd5j/emerging_trends_in) has announced the addition of Frost & Sullivan's new report "Emerging Trends in Optical Imaging Techniques for Drug Discovery, Clinical Diagnostics and Molecular Imaging" to their offering.
This Frost & Sullivan research service titled Emerging Trends in Optical Imaging Techniques for Drug Discovery, Clinical Diagnostics and Molecular Imaging describes a broad cross section of optical imaging research and clinical technology developments used for early disease detection and therapy guidance. The research service identifies and evaluates key optical imaging segments (optical coherence tomography, hyperspectral imaging, and near-infrared spectroscopy) that are of high interest to investors, estimating time for investment opportunity outcomes. The research service categorizes applications of emerging optical imaging technologies into four distinct areas-ophthalmic imaging, cardiac imaging, neuro imaging, and imaging of the gastrointestinal tracts. The insights provided here enables technology developers, who are either funded by an investment partner, or actively seeking investment opportunities, so that they can realign their developmental initiatives in accordance with adoption trends observed in the market.
Optical Coherence Tomography Surges to the Fore
Current optical imaging technologies provide reproducible, accurate, objective, quantitative assessment of tissue structures. However, there is still scope to improve. The marked progress in optical imaging techniques observed in recent years is instigating a new wave of business opportunities. Optical imaging at both the macroscopic and microscopic levels is being used intensively by clinicians for diagnosis and treatment-specific applications. Novel advances in optics, data acquisition methods, and image processing software have driven the development of optical imaging technologies, all of which can be used to image tissues and other biological entities with enhanced contrast and resolution capabilities.
Technology trends are moving from conventional confocal microscopy to optical coherence tomography (OCT) and the adoption of newer technologies such as adaptive optics and polarization imaging in ophthalmology, notes the analyst of this research. Several start-ups are developing innovative technologies, most of which are in the near-completion and advanced phases of clinical approval in the optical imaging market. OCT has gained much multidisciplinary research interest in recent years as a non-invasive optical imaging technique that can be used to perform cross-sectional in-situ imaging of microstructures in biological tissues. With OCT technology showing rapid progress, it is believed that many commercial devices addressing a plethora of clinical applications could hit the market over the next 4-5 years. OCT is truly an easy-to-use modality that provides digital cellular 2D and 3D imaging solutions for clinical and research pathology lab application needs on fixed or fresh tissue, explains the analyst. Further refinement could result in achieving significantly higher resolution capabilities and better differentiation of cancerous lesions, embryology studies, and stem cells (involving therapeutics research).
Expert Frost & Sullivan analysts thoroughly examine the following market segments in this research:
- Optical coherence tomography
- Hyperspectral imaging
- Near-infrared spectroscopy
- Ophthalmic imaging
- Cardiac imaging
- Neuro imaging
- Gastrointestinal tract imaging
Key Topics Covered:
1. Executive Summary
2. Technology Snapshot and Sectorwise Trends
3. Investment Opportunities Evaluation
4. Contact Details and Appendix
For more information visit http://www.researchandmarkets.com/research/4fhd5j/emerging_trends_in
Source: Frost & Sullivan